Surgery in Practice and Science (Mar 2024)

Utility of beta-lactam allergy assessment in patients receiving vancomycin for surgical prophylaxis

  • Kendall J. Tucker,
  • YoungYoon Ham,
  • Haley K. Holmer,
  • Caitlin M. McCracken,
  • Ellie Sukerman,
  • James S. Lewis, II,
  • Jessina C. McGregor

Journal volume & issue
Vol. 16
p. 100232

Abstract

Read online

Background: Beta-lactam antibiotics are first-line agents for most patients receiving antimicrobial prophylaxis in surgical procedures. Despite evidence showing low cross-reactivity between penicillins and cephalosporins, patients with beta-lactam allergies commonly receive vancomycin as an alternative to avoid allergic reaction. Methods: Adult patients receiving vancomycin for surgical prophylaxis with a reported beta-lactam allergy at our institution between August 2017 to July 2018 were retrospectively evaluated for potential eligibility for penicillin allergy testing and/or receipt of standard prophylaxis. Results: Among 830 patients who received vancomycin for surgical prophylaxis, 196 reported beta-lactam allergy and were included in the analysis. Approximately 40 % of surgeries were orthopedic. Of patients receiving vancomycin as first-line therapy, 189 (96.4 %) were potentially eligible for beta-lactam prophylaxis. Conclusions: Patients with beta-lactam allergies often qualify for receipt of a first-line antibiotic. An opportunity exists for improved allergy assessment as an antimicrobial stewardship intervention in surgical prophylaxis.

Keywords